The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Hodgkin lymphoma
Open accessAbstract
Hodgkin lymphoma (HL), a B cell-derived cancer, is one of the most common lymphomas. In HL, the tumor cells--Hodgkin and Reed-Sternberg (HRS) cells--are usually very rare in the tissue. Although HRS cells are derived from mature B cells, they have largely lost their B cell phenotype and show a very unusual co-expression of markers of various hematopoietic cell types. HRS cells show deregulated activation of multiple signaling pathways and transcription factors. The activation of these pathways and factors is partly mediated through interactions of HRS cells with various other types of cells in the microenvironment, but also through genetic lesions. The transforming events involved in the pathogenesis of HL are only partly understood, but mutations affecting the NF-κB and JAK/STAT pathways are frequent. The dependency of HRS cells on microenvironmental interactions and deregulated signaling pathways may offer novel strategies for targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Younes, A., Gopal, A. K., Smith, S. E., Ansell, S. M., Rosenblatt, J. D., Savage, K. J., Ramchandren, R., Bartlett, N. L., Cheson, B. D., de Vos, S., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0410 · Cited by 1,529
Self-citationBrentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
Younes, A., Bartlett, N. L., Leonard, J. P., Kennedy, D. A., Lynch, C. M., Sievers, E. L., & Forero-Torres, A. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002965 · Cited by 1,368
Green, M. R., Monti, S., Rodig, S. J., Juszczynski, P., Currie, T., O'Donnell, E., Chapuy, B., Takeyama, K., Neuberg, D., Golub, T. R., et al. (2010) · Blood · doi:10.1182/blood-2010-05-282780 · Cited by 1,305
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N., & Croce, C. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602266103 · Cited by 951
Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
Engert, A., Plütschow, A., Eich, H. T., Lohri, A., Dörken, B., Borchmann, P., Berger, B., Greil, R., Willborn, K. C., Wilhelm, M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000067 · Cited by 928
Self-citationGallamini, A., Hutchings, M., Rigacci, L., Specht, L., Merli, F., Hansen, M., Patti, C., Loft, A., Di Raimondo, F., D'Amore, F., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6525 · Cited by 846
Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 761
Kanzler, H., Küppers, R., Hansmann, M. L., & Rajewsky, K. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1495 · Cited by 742
Self-citationMultilineage gene expression precedes commitment in the hemopoietic system.
Hu, M., Krause, D., Greaves, M., Sharkis, S., Dexter, M., Heyworth, C., & Enver, T. (1997) · Genes & Development · doi:10.1101/gad.11.6.774 · Cited by 729
The biology of Hodgkin's lymphoma
Küppers, R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2542 · Cited by 688
Self-citationKüppers, R., Rajewsky, K., Zhao, M., Simons, G., Laumann, R., Fischer, R., & Hansmann, M. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10962 · Cited by 672
Self-citationEngert, A., Haverkamp, H., Kobe, C., Markova, J., Renner, C., Ho, A., Zijlstra, J., Král, Z., Fuchs, M., Hallek, M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61940-5 · Cited by 635
Self-citationMHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
Steidl, C., Shah, S. P., Woolcock, B. W., Rui, L., Kawahara, M., Farinha, P., Johnson, N. A., Zhao, Y., Telenius, A., Neriah, S. B., et al. (2011) · Nature · doi:10.1038/nature09754 · Cited by 615
Frequent inactivation of A20 in B-cell lymphomas
Kato, M., Sanada, M., Kato, I., Sato, Y., Takita, J., Takeuchi, K., Niwa, A., Chen, Y., Nakazaki, K., Nomoto, J., et al. (2009) · Nature · doi:10.1038/nature07969 · Cited by 555
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma
Marshall, N. A., Christie, L. E., Munro, L. R., Culligan, D. J., Johnston, P. W., Barker, R. N., & Vickers, M. A. (2004) · Blood · doi:10.1182/blood-2003-07-2594 · Cited by 509
Marafioti, T., Hummel, M., Foss, H.-D., Laumen, H., Korbjuhn, P., Anagnostopoulos, I., Lammert, H., Demel, G., Theil, J., Wirth, T., et al. (2000) · Blood · doi:10.1182/blood.v95.4.1443.004k55_1443_1450 · Cited by 499
Kilger, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1700 · Cited by 483
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Schmitz, R., Hansmann, M.-L., Bohle, V., Martin-Subero, J. I., Hartmann, S., Mechtersheimer, G., Klapper, W., Vater, I., Giefing, M., Gesk, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090528 · Cited by 481
Self-citationChemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease
Fermé, C., Eghbali, H., Meerwaldt, J. H., Rieux, C., Bosq, J., Berger, F., Girinsky, T., Brice, P., van't Veer, M. B., Walewski, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064601 · Cited by 450
ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
Viviani, S., Zinzani, P. L., Rambaldi, A., Brusamolino, E., Levis, A., Bonfante, V., Vitolo, U., Pulsoni, A., Liberati, A. M., Specchia, G., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100340 · Cited by 420
Myeloid or Lymphoid Promiscuity as a Critical Step in Hematopoietic Lineage Commitment
Miyamoto, T., Iwasaki, H., Reizis, B., Ye, M., Graf, T., Weissman, I. L., & Akashi, K. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00201-0 · Cited by 415
PD-1–PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
Yamamoto, R., Nishikori, M., Kitawaki, T., Sakai, T., Hishizawa, M., Tashima, M., Kondo, T., Ohmori, K., Kurata, M., Hayashi, T., et al. (2008) · Blood · doi:10.1182/blood-2007-05-085159 · Cited by 401
Jundt, F., Anagnostopoulos, I., Förster, R., Mathas, S., Stein, H., & Dörken, B. (2002) · Blood · doi:10.1182/blood.v99.9.3398 · Cited by 394
Lamprecht, B., Walter, K., Kreher, S., Kumar, R., Hummel, M., Lenze, D., Köchert, K., Bouhlel, M. A., Richter, J., Soler, E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2129 · Cited by 376
Brune, V., Tiacci, E., Pfeil, I., Döring, C., Eckerle, S., van Noesel, C. J. M., Klapper, W., Falini, B., von Heydebreck, A., Metzler, D., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080809 · Cited by 360
Self-citationSide population cells in human cancers
Wu, C., & Alman, B. A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.048 · Cited by 341
Marafioti, T., Hummel, M., Anagnostopoulos, I., Foss, H.-D., Falini, B., Delsol, G., Isaacson, P. G., Pileri, S., & Stein, H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370703 · Cited by 327
Juszczynski, P., Ouyang, J., Monti, S., Rodig, S. J., Takeyama, K., Abramson, J., Chen, W., Kutok, J. L., Rabinovich, G. A., & Shipp, M. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706017104 · Cited by 327
Weniger, M. A., Melzner, I., Menz, C. K., Wegener, S., Bucur, A. J., Dorsch, K., Mattfeldt, T., Barth, T. F. E., & Möller, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209151 · Cited by 322
Cooperative Epigenetic Modulation by Cancer Amplicon Genes
Rui, L., Emre, N. C. T., Kruhlak, M. J., Chung, H.-J., Steidl, C., Slack, G., Wright, G. W., Lenz, G., Ngo, V. N., Shaffer, A. L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.013 · Cited by 283
Clonal Deleterious Mutations in the Iκbα Gene in the Malignant Cells in Hodgkin's Lymphoma
Jungnickel, B., Staratschek-Jox, A., Bräuninger, A., Spieker, T., Wolf, J., Diehl, V., Hansmann, M.-L., Rajewsky, K., & Küppers, R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.395 · Cited by 283
Self-citationStein, H., Marafioti, T., Foss, H.-D., Laumen, H., Hummel, M., Anagnostopoulos, I., Wirth, T., Demel, G., & Falini, B. (2001) · Blood · doi:10.1182/blood.v97.2.496 · Cited by 275
Federico, M., Luminari, S., Iannitto, E., Polimeno, G., Marcheselli, L., Montanini, A., La Sala, A., Merli, F., Stelitano, C., Pozzi, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0910 · Cited by 274
Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells.
Joos, S., Küpper, M., Ohl, S., von Bonin, F., Mechtersheimer, G., Bentz, M., Marynen, P., Mӧller, P., Pfreundschuh, M. G., Trümper, L. H. P., et al. (2000) · PubMed · Cited by 273
Braeuninger, A., Küppers, R., Strickler, J. G., Wacker, H.-H., Rajewsky, K., & Hansmann, M.-L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9337 · Cited by 270
Self-citationEmmerich, F., Meiser, M., Hummel, M., Demel, G., Foss, H.-D., Jundt, F., Mathas, S., Krappmann, D., Scheidereit, C., Stein, H., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3129 · Cited by 261
Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling
Küppers, R., Klein, U., Schwering, I., Distler, V., Bräuninger, A., Cattoretti, G., Tu, Y., Stolovitzky, G. A., Califano, A., Hansmann, M.-L., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16624 · Cited by 243
Self-citationJoos, S., Menz, C. K., Wrobel, G., Siebert, R., Gesk, S., Ohl, S., Mechtersheimer, G., Trümper, L., Möller, P., Lichter, P., et al. (2002) · Blood · doi:10.1182/blood.v99.4.1381 · Cited by 238
A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma
Johnston, P. B., Inwards, D. J., Colgan, J. P., Laplant, B. R., Kabat, B. F., Habermann, T. M., Micallef, I. N., Porrata, L. F., Ansell, S. M., Reeder, C. B., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21664 · Cited by 219
Zheng, B., Fiumara, P., Li, Y. V., Georgakis, G., Snell, V., Younes, M., Vauthey, J. N., Carbone, A., & Younes, A. (2003) · Blood · doi:10.1182/blood-2002-11-3507 · Cited by 213
Rare Occurrence of Classical Hodgkin's Disease as a T Cell Lymphoma
Müschen, M., Rajewsky, K., Bräuninger, A., Baur, A. S., Oudejans, J. J., Roers, A., Hansmann, M.-L., & Küppers, R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.387 · Cited by 205
Self-citationRescue of “crippled” germinal center B cells from apoptosis by Epstein-Barr virus
Mancao, C., Altmann, M., Jungnickel, B., & Hammerschmidt, W. (2005) · Blood · doi:10.1182/blood-2005-06-2341 · Cited by 203
Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma
Bräuninger, A., Schmitz, R., Bechtel, D., Renné, C., Hansmann, M., & Küppers, R. (2006) · International Journal of Cancer · doi:10.1002/ijc.21716 · Cited by 202
Self-citationPathogenesis of Classical and Lymphocyte-Predominant Hodgkin Lymphoma
Schmitz, R., Stanelle, J., Hansmann, M.-L., & Küppers, R. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092209 · Cited by 197
Self-citationEnciso-Mora, V., Broderick, P., Ma, Y., Jarrett, R. F., Hjalgrim, H., Hemminki, K., van den Berg, A., Olver, B., Lloyd, A., Dobbins, S. E., et al. (2010) · Nature Genetics · doi:10.1038/ng.696 · Cited by 197
Self-citationMathas, S., Janz, M., Hummel, F., Hummel, M., Wollert-Wulf, B., Lusatis, S., Anagnostopoulos, I., Lietz, A., Sigvardsson, M., Jundt, F., et al. (2006) · Nature Immunology · doi:10.1038/ni1285 · Cited by 183
Contribution of the Epstein–Barr virus to the molecular pathogenesis of Hodgkin lymphoma
Kapatai, G., & Murray, P. G. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.050146 · Cited by 182
Ushmorov, A., Leithäuser, F., Sakk, O., Weinhaüsel, A., Popov, S. W., Möller, P., & Wirth, T. (2006) · Blood · doi:10.1182/blood-2005-09-3765 · Cited by 179
Wolf, J., Kapp, U., Bohlen, H., Kornacker, M., Schoch, C., Stahl, B., Mucke, S., von Kalle, C., Fonatsch, C., Schaefer, H., et al. (1996) · Blood · doi:10.1182/blood.v87.8.3418.bloodjournal8783418 · Cited by 178
Self-citationSteidl, C., Telenius, A., Shah, S. P., Farinha, P., Barclay, L., Boyle, M., Connors, J. M., Horsman, D. E., & Gascoyne, R. D. (2010) · Blood · doi:10.1182/blood-2009-12-257345 · Cited by 176
Dutton, A., Reynolds, G. M., Dawson, C. W., Young, L. S., & Murray, P. G. (2005) · The Journal of Pathology · doi:10.1002/path.1725 · Cited by 176
Circulating clonotypic B cells in classic Hodgkin lymphoma
Jones, R. J., Gocke, C. D., Kasamon, Y. L., Miller, C. B., Perkins, B., Barber, J. P., Vala, M. S., Gerber, J. M., Gellert, L. L., Siedner, M., et al. (2009) · Blood · doi:10.1182/blood-2008-11-189688 · Cited by 170
Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma
Navarro, A., Diaz, T., Martinez, A., Gaya, A., Pons, A., Gel, B., Codony, C., Ferrer, G., Martinez, C., Montserrat, E., et al. (2009) · Blood · doi:10.1182/blood-2009-02-204842 · Cited by 169
Spaepen, K., Stroobants, S., Dupont, P., Thomas, J., Vandenberghe, P., Balzarini, J., De Wolf‐Peeters, C., Mortelmans, L., & Verhoef, G. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03169.x · Cited by 169
Coexpression of BMI-1 and EZH2 Polycomb Group Genes in Reed-Sternberg Cells of Hodgkin’s Disease
Raaphorst, F. M., van Kemenade, F. J., Blokzijl, T., Fieret, E., Hamer, K. M., Satijn, D. P. E., Otte, A. P., & Meijer, C. J. L. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64583-x · Cited by 166
Gandhi, M. K., Moll, G., Smith, C., Dua, U., Lambley, E., Ramuz, O., Gill, D., Marlton, P., Seymour, J. F., & Khanna, R. (2007) · Blood · doi:10.1182/blood-2007-01-066100 · Cited by 165
Torlakovic, E., Tierens, A. M., Dang, H. D., & Delabie, J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63027-1 · Cited by 160
Tiacci, E., Döring, C., Brune, V., van Noesel, C. J. M., Klapper, W., Mechtersheimer, G., Falini, B., Küppers, R., & Hansmann, M. (2012) · Blood · doi:10.1182/blood-2012-05-428896 · Cited by 160
Self-citationInactivating I kappa B epsilon mutations in Hodgkin/Reed–Sternberg cells
Emmerich, F., Theurich, S., Hummel, M., Haefker, A., Vry, M. S., Döhner, K., Bommert, K., Stein, H., & Dörken, B. (2003) · The Journal of Pathology · doi:10.1002/path.1454 · Cited by 152
Carbone, A., Gloghini, A., Gruss, H. J., & Pinto, A. (1995) · Europe PMC (PubMed Central) · Cited by 150
Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma
Renné, C., Willenbrock, K., Küppers, R., Hansmann, M., & Bräuninger, A. (2005) · Blood · doi:10.1182/blood-2004-10-4008 · Cited by 149
Self-citationScheeren, F., Diehl, S., Smit, L., Beaumont, T., Naspetti, M., Bende, R., Blom, B., Karube, K., Ohshima, K., van Noesel, C. V., et al. (2008) · Blood · doi:10.1182/blood-2007-08-105643 · Cited by 146
Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile
Gibcus, J. H., Tan, L. P., Harms, G., Schakel, R. N., de Jong, D., Blokzijl, T., Möller, P., Poppema, S., Kroesen, B., & van den Berg, A. (2009) · Neoplasia · doi:10.1593/neo.08980 · Cited by 144
Mottok, A., Renné, C., Willenbrock, K., Hansmann, M., & Bräuninger, A. (2007) · Blood · doi:10.1182/blood-2007-03-082511 · Cited by 142
Self-citationWłodarska, I., Noyen, P., Maes, B., Martín-Subero, J. I., Siebert, R., Pauwels, P., Wolf‐Peeters, C. D., & Hagemeijer, A. (2002) · Blood · doi:10.1182/blood-2002-05-1592 · Cited by 132
Diepstra, A., Imhoff, G. W. V., Karim‐Kos, H. E., van den Berg, A., Meerman, G. J. T., Niens, M., Nolte, I. M., Bastiaannet, E., Schaapveld, M., Vellenga, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.0917 · Cited by 131
Dukers, D. F., van Galen, J. C., Giroth, C., Jansen, P. M., Sewalt, R. G. A. B., Otte, A. P., Kluin‐Nelemans, H. C., Meijer, C. J. L. M., & Raaphorst, F. M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63175-6 · Cited by 125
The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma
Borchmann, P., Treml, J., Hansen, H. P., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0515 · Cited by 114
Roosbroeck, K. V., Cox, L., Tousseyn, T., Lahortiga, I., Gielen, O., Cauwelier, B., Paepe, P. D., Verhoef, G. E. G., Marynen, P., Vandenberghe, P., et al. (2011) · Blood · doi:10.1182/blood-2010-06-291310 · Cited by 113
Dutton, A., Woodman, C. B. J., Chukwuma, M. B., Last, J. I. K., Wei, W., Vockerodt, M., Baumforth, K. R. N., Flavell, J. R., Rowe, M., Taylor, A. M. R., et al. (2006) · Blood · doi:10.1182/blood-2006-05-020545 · Cited by 108
Highly increased familial risks for specific lymphoma subtypes
Goldin, L. R., Björkholm, M., Kristinsson, S. Y., Turesson, I., & Landgren, O. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07721.x · Cited by 101
Aberrant Expression of ID2, a Suppressor of B-Cell-Specific Gene Expression, in Hodgkin's Lymphoma
Renné, C., Martín-Subero, J. I., Eickernjäger, M., Hansmann, M., Küppers, R., Siebert, R., & Bräuninger, A. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060020 · Cited by 101
Self-citationLake, A., Shield, L. A., Cordano, P., Chui, D. T. Y., Osborne, J., Crae, S., Wilson, K. S., Tosi, S., Knight, S. J. L., Gesk, S., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24502 · Cited by 98
Genetic lesions of the TRAF 3 and MAP 3K14 genes in classical H odgkin lymphoma
Otto, C., Giefing, M., Massow, A., Vater, I., Gesk, S., Schlesner, M., Richter, J., Klapper, W., Hansmann, M., Siebert, R., et al. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09113.x · Cited by 95
Self-citationMartín-Subero, J. I., Wlodarska, I., Bastard, C., Picquenot, J.-M., Höppner, J., Giefing, M., Klapper, W., & Siebert, R. (2006) · Blood · doi:10.1182/blood-2005-09-3843 · Cited by 90
Greiner, A., Tobollik, S., Buettner, M. J., Jungnickel, B., Herrmann, K., Kremmer, E., & Niedobitek, G. (2005) · The Journal of Pathology · doi:10.1002/path.1746 · Cited by 87
Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma
Saarinen, S., Aavikko, M., Aittomäki, K., Launonen, V., Lehtonen, R., Franssila, K., Lehtonen, H. J., Kaasinen, E., Broderick, P., Tarkkanen, J., et al. (2011) · Blood · doi:10.1182/blood-2011-03-341560 · Cited by 83
Jundt, F., Açıkgöz, Ö., Kwon, S.-H., Schwarzer, R., Anagnostopoulos, I., Wiesner, B., Mathas, S., Hummel, M., Stein, H., Reichardt, H. M., et al. (2008) · Leukemia · doi:10.1038/leu.2008.101 · Cited by 79
Sánchez‐Beato, M., Sánchez, E., García, J. F., Pérez‐Rosado, A., Montoya, M. C., Fraga, M. F., Artiga, M. J., Navarrete, M., Abraira, V., Morente, M. M., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1661 · Cited by 65
Stanelle, J., Döring, C., Hansmann, M., & Küppers, R. (2010) · Blood · doi:10.1182/blood-2010-01-265827 · Cited by 64
Self-citationSchumacher, M. A., Schmitz, R., Brune, V., Tiacci, E., Döring, C., Hansmann, M., Siebert, R., & Küppers, R. (2009) · Haematologica · doi:10.3324/haematol.2009.010157 · Cited by 64
Self-citationSalipante, S. J., Mealiffe, M. E., Wechsler, J., Krem, M. M., Liu, Y., Namkoong, S., Bhagat, G., Kirchhoff, T., Offit, K., Lynch, H. T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904231106 · Cited by 61
Bräuninger, A., Wacker, H., Rajewsky, K., Küppers, R., & Hansmann, M. (2003) · PubMed · Cited by 61
Self-citationAmmerpohl, O., Haake, A., Pellissery, S., Giefing, M., Richter, J., Bálint, B., Kulis, M., Le, J. M., Bibikova, M. V., Drexler, H. G., et al. (2011) · Leukemia · doi:10.1038/leu.2011.194 · Cited by 51
Self-citationVlierberghe, P. V., Weer, A. D., Mestdagh, P., Feys, T., Preter, K. D., Paepe, P. D., Lambein, K., Vandesompele, J., Roy, N. V., Verhasselt, B., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07909.x · Cited by 50
Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma
Schmidt, A., Schmitz, R., Giefing, M., Martín-Subero, J. I., Gesk, S., Vater, I., Massow, A., Maggio, E. M., Schneider, M., Hansmann, M., et al. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20789 · Cited by 49
Self-citationShafer, J. A., Cruz, C. C., Leen, A. M., Ku, S., Lu, A., Rousseau, A., Heslop, H. E., Rooney, C. M., Bollard, C. M., & Foster, A. E. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428191003713968 · Cited by 48
MiR‐17/106b seed family regulates p21 in Hodgkin's lymphoma
Gibcus, J. H., Kroesen, B., Koster, R., Halsema, N., de Jong, D., de Jong, S., Poppema, S., Kluiver, J. L., Diepstra, A., & van den Berg, A. (2011) · The Journal of Pathology · doi:10.1002/path.2958 · Cited by 38
Tumorigenic Potential of Mononucleated Small Cells of Hodgkin Lymphoma Cell Lines
Ikeda, J., Mamat, S., Tian, T., Wang, Y., Rahadiani, N., Aozasa, K., & Morii, E. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100089 · Cited by 29
Research works printed but not linked: 33
- 10.1056/NEJM199803123381113 · doi:10.1056/nejm199803123381113
- Bräuninger, 2003, Cancer Res., 63, 1644
- Seitz, 2000, Blood., 95, 3020, 10.1182/blood.V95.10.3020 · doi:10.1182/blood.v95.10.3020
- 10.1002/stem.5530060606 · doi:10.1002/stem.5530060606
- 10.1182/blood.V97.3.818 · doi:10.1182/blood.v97.3.818
- 10.1182/blood-2009-06-229583 · doi:10.1182/blood-2009-06-229583
- 10.1111/j.1349-7006.2010.01693.x · doi:10.1111/j.1349-7006.2010.01693.x
- 10.1182/blood-2002-03-0839 · DOI
- 10.1046/j.1365-2559.2000.00830.x · doi:10.1046/j.1365-2559.2000.00830.x
- Küppers, 2003, J Clin Invest., 111, 529, 10.1172/JCI200316624 · doi:10.1172/jci200316624
- Anagnostopoulos, 1989, Blood., 74, 810, 10.1182/blood.V74.2.810.810 · doi:10.1182/blood.v74.2.810.810
- 10.1146/annurev.immunol.16.1.471 · doi:10.1146/annurev.immunol.16.1.471
- 10.1182/blood-2005-06-2342 · doi:10.1182/blood-2005-06-2342
- Weber-Matthiesen, 1995, Blood., 86, 1464, 10.1182/blood.V86.4.1464.bloodjournal8641464 · doi:10.1182/blood.v86.4.1464.bloodjournal8641464
- 10.1158/0008-5472.CAN-06-1992 · doi:10.1158/0008-5472.can-06-1992
- 10.1016/j.cancergencyto.2008.06.007 · doi:10.1016/j.cancergencyto.2008.06.007
- 10.1182/blood.V99.4.1474 · doi:10.1182/blood.v99.4.1474
- Joos, 2000, Cancer Res., 60, 549
- Kapp, 1993, Blood., 82, 1247, 10.1182/blood.V82.4.1247.1247 · doi:10.1182/blood.v82.4.1247.1247
- Vockerodt, 1998, Blood., 92, 2899, 10.1182/blood.V92.8.2899 · doi:10.1182/blood.v92.8.2899
- Carbone, 1995, Am J Pathol., 147, 912
- 10.1111/j.1440-1827.1998.tb03821.x · doi:10.1111/j.1440-1827.1998.tb03821.x
- 10.1136/jcp.48.2.160 · doi:10.1136/jcp.48.2.160
- Engert A Horning SJ Hodgkin Lymphoma. Heidelberg, Germany: Springer; 2011. · doi:10.1007/978-3-642-12780-9
- 10.1007/s00066-008-1882-7 · doi:10.1007/s00066-008-1882-7
- 10.1200/JCO.2006.07.0482 · doi:10.1200/jco.2006.07.0482
- Raemaekers, 2002, Eur J Cancer., 38, S107, 10.1016/S0959-8049(01)00446-4 · doi:10.1016/s0959-8049(01)00446-4
- 10.1093/annonc/mdi323 · doi:10.1093/annonc/mdi323
- 10.1182/blood-2002-08-2644 · doi:10.1182/blood-2002-08-2644
- 10.1182/blood-2007-03-078725 · doi:10.1182/blood-2007-03-078725
- 10.1093/annonc/mdl302 · doi:10.1093/annonc/mdl302
- Younes, 2011, J Clin Oncol., 29
- 10.1111/j.1365-2141.2009.07963.x · doi:10.1111/j.1365-2141.2009.07963.x
Cited by
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Jiang, N., Dai, Q., Su, X., Fu, J., Feng, X., & Peng, J. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05435-1 · Cited by 571
Bollard, C. M., Gottschalk, S., Torrano, V., Diouf, O., Ku, S., Hazrat, Y., Carrum, G., Ramos, C., Fayad, L., Shpall, E. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.5304 · Cited by 503
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
Ramos, C. A., Grover, N. S., Beaven, A. W., Lulla, P. D., Wu, M.-F., Ivanova, A., Wang, T., Shea, T. C., Rooney, C. M., Dittus, C., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01342 · Cited by 386
Metadata
- Authors
- Küppers, R., Engert, A., & Hansmann, M.-L.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-01
- Volume
- 122
- Issue
- 10
- Pages
- 3439-3447
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4252401126
- Cited by
- 286
- References
- 90
- FWCI
- 13.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.